Morphocell Technologies
Transforming the treatment of liver disease.
Morphocell Technologies Inc. is a regenerative medicine company focused on the development and commercialization of stem cell therapies and engineered tissue implants that target liver failure. The Company is supported by Series A investment to achieve Phase 1 clinical trials. Morphocell Technologies aims at bringing to market the first effective treatment for acute, chronic and acute-on-chronic liver failure.
Morphocell Technologies Offices
OnSite Workspace
Employees work from physical offices.
Typical time on-site:
None
Canada
